Albert Bourla - Feb 23, 2022 Form 4 Insider Report for PFIZER INC (PFE)

Role
Chairman & CEO, Director
Signature
Susan E. Grant, by power of atty., for Albert Bourla
Stock symbol
PFE
Transactions as of
Feb 23, 2022
Transactions value $
-$1,758,047
Form type
4
Date filed
2/25/2022, 04:06 PM
Previous filing
Feb 17, 2022
Next filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Tax liability -$1.76M -37.5K -15.16% $46.87 210K Feb 23, 2022 Direct F1
holding PFE Common Stock 3.99K Feb 23, 2022 By Rule 16b-3 Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Award $0 +412K $0.00 412K Feb 24, 2022 Common Stock 412K $45.96 Direct F2
transaction PFE Stock Appreciation Rights Award $0 +362K $0.00 362K Feb 24, 2022 Common Stock 362K $45.96 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon).
F2 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F3 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.